Prenetics Global director receives 2,000 shares
The reported post-transaction positions included 8,001 directly held Class A Ordinary Shares and 16,003 Restricted Stock Units.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Prenetics Global Ltd (PRE) director Hudson Blake Leogrande reported settlement of 2,000 vested Restricted Stock Units on October 4, 2026, with 2,000 Class A Ordinary Shares issued and delivered. The RSUs vested on June 4, 2026, under the company's 2022 Share Incentive Plan. Following the transactions, his reported direct holdings were 8,001 Class A Ordinary Shares and 16,003 Restricted Stock Units.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F2 | 2,000 | $0.00 | $0.00 |
| Exercise | Class A Ordinary Share, par value $0.0015 per share F1 | 2,000 | $0.00 | $0.00 |
Footnotes (2)
- F1. Represents 2,000 Class A Ordinary Shares of the Issuer issued and delivered upon settlement of vested Restricted Stock Units ("RSUs") granted under the Issuer's 2022 Share Incentive Plan.
- F2. Each RSU, granted under the Issuer's 2022 Share Incentive Plan, represents a contingent right to receive one Class A Ordinary Share. The 2,000 RSUs vested on June 4, 2026.
Key Figures
Key Terms
Restricted Stock Units financial
contingent right technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What plan covered the RSUs reported by Hudson Blake Leogrande?
AI-generated analysis. How Rhea-AI works. Not financial advice.